Development
Core Scientific, Inc.
CORZ
$12.19
$0.262.18%
NASDAQ
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -0.29% | 0.06% | |||
| Total Other Revenue | 35.05% | -14.45% | |||
| Total Revenue | 25.71% | -11.04% | |||
| Cost of Revenue | 5.28% | 8.37% | |||
| Gross Profit | 154.88% | -58.28% | |||
| SG&A Expenses | 14.54% | -3.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -97.80% | 62.24% | |||
| Total Operating Expenses | 6.44% | 6.26% | |||
| Operating Income | 179.41% | -221.37% | |||
| Income Before Tax | -376.11% | -349.37% | |||
| Income Tax Expenses | 194.74% | -11.63% | |||
| Earnings from Continuing Operations | -375.61% | -344.34% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -375.61% | -344.34% | |||
| EBIT | 179.41% | -221.37% | |||
| EBITDA | 223.23% | -58.40% | |||
| EPS Basic | -372.21% | -337.40% | |||
| Normalized Basic EPS | -514.88% | -238.71% | |||
| EPS Diluted | -366.82% | -347.15% | |||
| Normalized Diluted EPS | -514.88% | -238.71% | |||
| Average Basic Shares Outstanding | 0.69% | 1.78% | |||
| Average Diluted Shares Outstanding | 0.69% | 1.78% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||